Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.

[1]  William Grossman,et al.  Grossman & Baim's Cardiac Catheterization, Angiography, and Intervention , 2013 .

[2]  Yoshihiro Fukumoto,et al.  Rho-kinase: important new therapeutic target in cardiovascular diseases. , 2011, American journal of physiology. Heart and circulatory physiology.

[3]  T. Glück.  Long-Term Prognosis of , 2011 .

[4]  K. Chayama,et al.  Calcium channel blocker and Rho-associated kinase activity in patients with hypertension , 2011, Journal of hypertension.

[5]  K. Hsu,et al.  Interactions among gender, age, hypertension and C‐reactive protein in coronary vasospasm , 2010, European journal of clinical investigation.

[6]  M. Hung.  Current advances in the understanding of coronary vasospasm. , 2010, World journal of cardiology.

[7]  P. Ganz,et al.  Statins inhibit Rho kinase activity in patients with atherosclerosis. , 2009, Atherosclerosis.

[8]  J. Liao,et al.  Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation , 2009, Circulation.

[9]  F. Luscinskas,et al.  ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. , 2008, The Journal of clinical investigation.

[10]  H. Yasue,et al.  Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. , 2008, Journal of cardiology.

[11]  J. Liao,et al.  Rho Kinase (ROCK) Inhibitors , 2007, Journal of cardiovascular pharmacology.

[12]  P. Ganz,et al.  Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease , 2006, Circulation research.

[13]  K. Nakao,et al.  A −786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine , 2006, Pharmacogenetics and genomics.

[14]  Takahiro Shimizu,et al.  Calcium Channel Blockades Exhibit Anti-Inflammatory and Antioxidative Effects by Augmentation of Endothelial Nitric Oxide Synthase and the Inhibition of Angiotensin Converting Enzyme in the NG-Nitro-L-Arginine Methyl Ester-Induced Hypertensive Rat Aorta: Vasoprotective Effects beyond the Blood Press , 2005, Hypertension Research.

[15]  A. Takeshita,et al.  Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[16]  Céline Marionneau,et al.  RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation* , 2003, The Journal of Biological Chemistry.

[17]  A. Takeshita,et al.  Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[18]  H. Shimokawa,et al.  Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase , 2002, Circulation.

[19]  A. Takeshita,et al.  Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.

[20]  R. Webb,et al.  Nitric Oxide Induces Dilation of Rat Aorta via Inhibition of Rho-Kinase Signaling , 2002, Hypertension.

[21]  J. Keaney.  Grossman's cardiac catheterization, angiography, and intervention, 6th ed , 2001 .

[22]  A. Ridley,et al.  Monocyte Adhesion and Spreading on Human Endothelial Cells Is Dependent on Rho-regulated Receptor Clustering , 1999, The Journal of cell biology.

[23]  J. Brown,et al.  Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. , 1999, Circulation research.

[24]  K. Nakao,et al.  Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.

[25]  Hirofumiyasue,et al.  Nitric Oxide Activity Is Deficient in Spasm Arteries of Patients With Coronary Spastic Angina , 1996 .

[26]  M. Horie,et al.  Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.

[27]  A. Maseri,et al.  Long-term prognosis of "variant" angina with medical treatment. , 1980, The American journal of cardiology.

[28]  M. Cheitlin.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2009 .

[29]  T. Aizawa,et al.  Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. , 1999, Journal of the American College of Cardiology.